| scholarly article | Q13442814 |
| P819 | ADS bibcode | 1988PNAS...85.1667R |
| P356 | DOI | 10.1073/PNAS.85.5.1667 |
| P932 | PMC publication ID | 279835 |
| P698 | PubMed publication ID | 3422754 |
| P5875 | ResearchGate publication ID | 19733090 |
| P50 | author | Mariano Esteban | Q30004051 |
| Dolores Rodríguez | Q62671130 | ||
| P2093 | author name string | J F Rodriguez | |
| J R Rodriguez | |||
| E B McGowan | |||
| P2860 | cites work | Firefly luciferase gene: structure and expression in mammalian cells | Q29616519 |
| Functional analysis of the 5' flanking sequence of a vaccinia virus late gene | Q33880222 | ||
| Firefly luciferase is targeted to peroxisomes in mammalian cells | Q34623298 | ||
| Cloning of firefly luciferase cDNA and the expression of active luciferase in Escherichia coli | Q36489916 | ||
| Use of a hybrid vaccinia virus-T7 RNA polymerase system for expression of target genes | Q36843702 | ||
| In vitro mutagenesis of the promoter region for a vaccinia virus gene: evidence for tandem early and late regulatory signals | Q36900146 | ||
| Virus attenuation and identification of structural proteins of vaccinia virus that are selectively modified during virus persistence | Q36917271 | ||
| Vaccinia virus expression vector: coexpression of beta-galactosidase provides visual screening of recombinant virus plaques | Q36952733 | ||
| Vaccinia virus expression vectors | Q39743899 | ||
| Conserved TAAAT motif in vaccinia virus late promoters: overlapping TATA box and site of transcription initiation | Q42118758 | ||
| Isolation and characterization of attenuated mutants of vaccinia virus | Q44200354 | ||
| A 14K envelope protein of vaccinia virus with an important role in virus-host cell interactions is altered during virus persistence and determines the plaque size phenotype of the virus | Q44342775 | ||
| The pathogenesis of the acute exanthems; an interpretation based on experimental investigations with mousepox; infectious ectromelia of mice | Q44887383 | ||
| Decreased virulence of recombinant vaccinia virus expression vectors is associated with a thymidine kinase-negative phenotype | Q45827796 | ||
| Determination of the promoter region of an early vaccinia virus gene encoding thymidine kinase | Q45831479 | ||
| Transient and Stable Expression of the Firefly Luciferase Gene in Plant Cells and Transgenic Plants | Q56158065 | ||
| Recombinant vaccinia viruses as vaccines | Q70006928 | ||
| The purification fo four strains of poxvirus | Q76491615 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | virus | Q808 |
| Vaccinia virus | Q1986297 | ||
| P1104 | number of pages | 5 | |
| P304 | page(s) | 1667-1671 | |
| P577 | publication date | 1988-03-01 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Expression of the firefly luciferase gene in vaccinia virus: a highly sensitive gene marker to follow virus dissemination in tissues of infected animals | |
| P478 | volume | 85 |
| Q43861566 | A heterologous prime-boost regime using DNA and recombinant vaccinia virus expressing the Leishmania infantum P36/LACK antigen protects BALB/c mice from cutaneous leishmaniasis. |
| Q40678190 | A single transcription factor binds to two divergent sequence elements with a common function in cardiac myosin light chain-2 promoter |
| Q35861821 | Activation of the double-stranded RNA (dsRNA)-activated human protein kinase in vivo in the absence of its dsRNA binding domain |
| Q37216414 | An siRNA screen for ATG protein depletion reveals the extent of the unconventional functions of the autophagy proteome in virus replication. |
| Q39537906 | Apoptosis and necrosis in vaccinia virus-infected HeLa G and BSC-40 cells |
| Q37365367 | Application of bioluminescence imaging to the prediction of lethality in vaccinia virus-infected mice |
| Q37116052 | Applications of bioluminescence imaging to antiviral research and therapy: multiple luciferase enzymes and quantitation |
| Q36911682 | Attenuated and replication-competent vaccinia virus strains M65 and M101 with distinct biology and immunogenicity as potential vaccine candidates against pathogens. |
| Q39592790 | Attenuated modified vaccinia virus Ankara can be used as an immunizing agent under conditions of preexisting immunity to the vector |
| Q24647918 | Autophosphorylation sites participate in the activation of the double-stranded-RNA-activated protein kinase PKR |
| Q68264989 | Avian retroviral expression of luciferase |
| Q39589039 | Biology of attenuated modified vaccinia virus Ankara recombinant vector in mice: virus fate and activation of B- and T-cell immune responses in comparison with the Western Reserve strain and advantages as a vaccine |
| Q45253354 | Bioluminescence imaging of vaccinia virus: effects of interferon on viral replication and spread |
| Q39315677 | Blocking HIV-1 infection via CCR5 and CXCR4 receptors by acting in trans on the CCR2 chemokine receptor |
| Q45741970 | Chimeras between the human immunodeficiency virus (HIV-1) Env and vaccinia virus immunogenic proteins p14 and p39 generate in mice broadly reactive antibodies and specific activation of CD8+ T cell responses to Env. |
| Q40107685 | Construction of fowlpox virus vectors with intergenic insertions: expression of the beta-galactosidase gene and the measles virus fusion gene. |
| Q39894399 | Detection of a single genetically modified bacterial cell in soil by using charge coupled device-enhanced microscopy |
| Q33289770 | Detection of novel secondary metabolites. |
| Q90434148 | Development of Stable Rotavirus Reporter Expression Systems |
| Q28477584 | Dissection of the influenza A virus endocytic routes reveals macropinocytosis as an alternative entry pathway |
| Q33818201 | Diversity in viral anti-PKR mechanisms: a remarkable case of evolutionary convergence |
| Q36827391 | Effects of postchallenge administration of ST-246 on dissemination of IHD-J-Luc vaccinia virus in normal mice and in immune-deficient mice reconstituted with T cells |
| Q45388153 | Ethacrynic and alpha-lipoic acids inhibit vaccinia virus late gene expression. |
| Q44351290 | Expression and quantification of firefly luciferase under control ofRhizobium meliloti symbiotic promoters |
| Q36423945 | Expression of the E3L gene of vaccinia virus in transgenic mice decreases host resistance to vaccinia virus and Leishmania major infections. |
| Q35769197 | Fiat Luc: Bioluminescence Imaging Reveals In Vivo Viral Replication Dynamics |
| Q37368665 | Functional dissection of the mouse tyrosinase locus control region identifies a new putative boundary activity |
| Q31961735 | Green fluorescent protein expressed by a recombinant vaccinia virus permits early detection of infected cells by flow cytometry |
| Q33838030 | Highly attenuated vaccinia virus mutants for the generation of safe recombinant viruses |
| Q37336673 | Highly sensitive real-time in vivo imaging of an influenza reporter virus reveals dynamics of replication and spread |
| Q42160090 | Identification of glucocorticoid response element of the rat TRH gene |
| Q34111739 | Imaging of light emission from the expression of luciferases in living cells and organisms: a review |
| Q28742982 | Improved NYVAC-based vaccine vectors |
| Q44340720 | Improving recombinant MVA immune responses: potentiation of the immune responses to HIV-1 with MVA and DNA vectors expressing Env and the cytokines IL-12 and IFN-gamma |
| Q41928242 | In-vivo monitoring of infectious diseases in living animals using bioluminescence imaging. |
| Q34006463 | Inhibition of host translation by virus infection in vivo |
| Q33627613 | Insertion of vaccinia virus C7L host range gene into NYVAC-B genome potentiates immune responses against HIV-1 antigens |
| Q36655962 | Insertional inactivation of the vaccinia virus 32-kilodalton gene is associated with attenuation in mice and reduction of viral gene expression in polarized epithelial cells |
| Q39591919 | Interleukin-12 (IL-12) enhancement of the cellular immune response against human immunodeficiency virus type 1 env antigen in a DNA prime/vaccinia virus boost vaccine regimen is time and dose dependent: suppressive effects of IL-12 boost are mediate |
| Q37308720 | Involvement of the cellular phosphatase DUSP1 in vaccinia virus infection. |
| Q36539092 | Kinetics of recombinant adenovirus type 5, vaccinia virus, modified vaccinia ankara virus, and DNA antigen expression in vivo and the induction of memory T-lymphocyte responses |
| Q39992823 | Lytic infection with vaccinia virus activates caspases in a Bcl-2-inhibitable manner. |
| Q41679113 | Membrane-permeable luciferin esters for assay of firefly luciferase in live intact cells |
| Q24634727 | Molecular biology of bacterial bioluminescence |
| Q40962256 | Mucosal and systemic immune responses induced after oral delivery of vaccinia virus recombinants |
| Q48746513 | Non-invasive imaging of mouse hepatitis coronavirus infection reveals determinants of viral replication and spread in vivo. |
| Q36781179 | Plaque size phenotype as a selectable marker to generate vaccinia virus recombinants |
| Q35110971 | Postchallenge administration of brincidofovir protects healthy and immune-deficient mice reconstituted with limited numbers of T cells from lethal challenge with IHD-J-Luc vaccinia virus |
| Q35741602 | Potential for development of an Escherichia coli-based biosensor for assessing bioavailable methionine: a review |
| Q37216610 | Prowling wolves in sheep's clothing: the search for tumor stem cells |
| Q36784011 | Regulated expression of nuclear genes by T3 RNA polymerase and lac repressor, using recombinant vaccinia virus vectors |
| Q35487966 | Relationships among dissemination of primary parainfluenza virus infection in the respiratory tract, mucosal and peripheral immune responses, and protection from reinfection: a noninvasive bioluminescence-imaging study |
| Q38756727 | Response of Three Different Viruses to Interferon Priming and Dithiothreitol Treatment of Avian Cells. |
| Q45728663 | The combination of DNA vectors expressing IL-12 + IL-18 elicits high protective immune response against cutaneous leishmaniasis after priming with DNA-p36/LACK and the cytokines, followed by a booster with a vaccinia virus recombinant expressing p36 |
| Q36798882 | The purified 14-kilodalton envelope protein of vaccinia virus produced in Escherichia coli induces virus immunity in animals. |
| Q33987473 | Thy1+ NK [corrected] cells from vaccinia virus-primed mice confer protection against vaccinia virus challenge in the absence of adaptive lymphocytes |
| Q41595032 | Transient expression assay in a baculovirus system using firefly luciferase gene as a reporter |
| Q36655491 | Vaccinia virus nucleoside triphosphate phosphohydrolase I controls early and late gene expression by regulating the rate of transcription. |
| Q36688197 | Vaccinia virus preferentially enters polarized epithelial cells through the basolateral surface |
| Q34211635 | Vaccinia virus vectors: new strategies for producing recombinant vaccines |
| Q40976979 | Wiskott-Aldrich syndrome protein is needed for vaccinia virus pathogenesis |
Search more.